Annual Out-of-Pocket Costs for Insulin Nearly Doubled Over a Decade for Medicare Part D Enrollees April 4, 2019 Slide Out-of-pocket insulin costs for Medicare Part D enrollees with incomes too high to qualify for low-income subsidies increased 81% from 2007 to 2016. Learn more in the latest Chart of the Week.
Initiative 18|11: What Can We Do About The Cost Of Health Care? January 15, 2019 Issue Brief This conference report summarizes discussions at a March 2018 conference in Washington with 30 leaders from the health care community to launch Initiative 18/11, a partnership between the Society of Actuaries and KFF to address the rising cost of health care in the United States. It also lays out the next steps for the initiative.
Why are Healthcare Prices So High, and What can be Done about Them? May 9, 2018 Event An archived webcast of this forum is now available at http://www.healthsystemtracker.org . Nearly a fifth of the United States’ economy goes to healthcare spending – a far larger share than in any other large, wealthy country in the world. Research suggests that price, rather than the volume of services, is…
Web Event: Rx Drugs and the U.S. Health System – A Conversation about Election-Cycle Proposals for Lowering Costs October 5, 2016 Event On Wednesday, October 5, from noon to 1 p.m. ET, the Kaiser Family Foundation will host a web conversation to discuss proposals for controlling prescription drug costs, examine pros and cons of the ideas, and assess the likelihood that the plans will be enacted.
Web Event: Rx Drugs and the U.S. Health System: A Conversation about Medicare Prescription Drug Costs September 7, 2016 Event On Wednesday, September 7, from noon to 1 p.m. ET, the Kaiser Family Foundation hosted a web conversation to discuss trends in Medicare prescription drug spending, as well as proposals to reduce costs and forecasts of what beneficiaries can expect in coming years.
Web Event: Rx Drugs and the U.S. Health System – A Conversation About Drug Prices July 7, 2016 Event The Kaiser Family Foundation will host a web conversation to discuss the drivers of recent and forecasted trends in prescription drug spending and examine how drug prices are set.
Visualizing Health Policy: Recent Trends in Prescription Drug Costs April 5, 2016 Infographic This Visualizing Health Policy infographic with JAMA spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices.
Visualizing Health Policy: Recent Trends in Prescription Drug Costs April 5, 2016 News Release This Visualizing Health Policy infographic spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices. Prescription drug spending rose sharply in 2014, driven by growth in expenditures on specialty drugs, including medications to treat cancer and hepatitis C. Medicare’s spending on prescription pharmaceuticals also has risen, largely…
A New Way of Measuring Health Costs Sheds Light on Recent Health Spending Trends March 29, 2016 Issue Brief National health spending started to grow more rapidly recently after several years of unusually slow growth. This analysis from the Kaiser Family Foundation and the federal Bureau of Economic Analysis helps to dissect why that may be happening. Using recently-released disease-based health spending data compiled by the federal government, the analysis finds…
